FI873593A0 - Nya applikationsformer foer -interferon. - Google Patents

Nya applikationsformer foer -interferon.

Info

Publication number
FI873593A0
FI873593A0 FI873593A FI873593A FI873593A0 FI 873593 A0 FI873593 A0 FI 873593A0 FI 873593 A FI873593 A FI 873593A FI 873593 A FI873593 A FI 873593A FI 873593 A0 FI873593 A0 FI 873593A0
Authority
FI
Finland
Prior art keywords
applikationsformer
nya
foer
interferon
nya applikationsformer
Prior art date
Application number
FI873593A
Other languages
English (en)
Other versions
FI873593A (fi
FI89007C (fi
FI89007B (fi
Inventor
Robert Becker
Bernd Kruss
Leonhard Schilk
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of FI873593A0 publication Critical patent/FI873593A0/fi
Publication of FI873593A publication Critical patent/FI873593A/fi
Application granted granted Critical
Publication of FI89007B publication Critical patent/FI89007B/fi
Publication of FI89007C publication Critical patent/FI89007C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
FI873593A 1986-08-21 1987-08-20 Foerfarande foer framstaellning av nya applikationsformer foer -interferon FI89007C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863628468 DE3628468A1 (de) 1986-08-21 1986-08-21 Neue applikationsformen fuer (alpha)-interferone
DE3628468 1986-08-21

Publications (4)

Publication Number Publication Date
FI873593A0 true FI873593A0 (fi) 1987-08-20
FI873593A FI873593A (fi) 1988-02-22
FI89007B FI89007B (fi) 1993-04-30
FI89007C FI89007C (fi) 1993-08-10

Family

ID=6307914

Family Applications (1)

Application Number Title Priority Date Filing Date
FI873593A FI89007C (fi) 1986-08-21 1987-08-20 Foerfarande foer framstaellning av nya applikationsformer foer -interferon

Country Status (14)

Country Link
US (1) US4824674A (fi)
EP (1) EP0258683A3 (fi)
JP (1) JPS6351338A (fi)
KR (1) KR880002541A (fi)
AU (1) AU590958B2 (fi)
CA (1) CA1313131C (fi)
DE (1) DE3628468A1 (fi)
DK (1) DK434087A (fi)
FI (1) FI89007C (fi)
IL (1) IL83585A0 (fi)
NO (1) NO873513L (fi)
NZ (1) NZ221497A (fi)
PT (1) PT85561B (fi)
ZA (1) ZA876166B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88233A (en) * 1987-11-03 1993-08-18 Genentech Inc Gamma interferon formulation
US5151265A (en) * 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition
DE3826055A1 (de) * 1988-07-30 1990-02-01 Boehringer Mannheim Gmbh Mit reagenz abloesbar impraegnierte traegermatrix
CA2120950A1 (en) * 1991-10-11 1993-04-15 Mark C. Gillies Treating ophthalmic fibrosis using interferon-alpha
US5863530A (en) * 1991-10-11 1999-01-26 Spruson & Ferguson Treating ophthalmic fibrosis using interferon-α
US5358708A (en) * 1993-01-29 1994-10-25 Schering Corporation Stabilization of protein formulations
DE19508029C2 (de) * 1995-03-07 1997-10-09 Richard Prof Dr Sueverkruep Darreichungsform zur äußerlichen Applikation von ophthalmischen Arzneistoffen und Verfahren zur Herstellung derselben
NZ509029A (en) * 1998-06-22 2002-11-26 Unihart Corp Sticking plaster for controlled release of natural interferon for transcutaneous absorption
US20030206945A1 (en) * 2000-12-20 2003-11-06 Giulio Tarro Sticking plaster for controlled release of natural interferon
UY27373A1 (es) * 2001-07-09 2003-02-28 Schering Ag Formulaciones de interferón beta-humano
CN1596091A (zh) 2001-12-04 2005-03-16 迪斯酋有限公司 用于承重用途的植入体
MX2013005024A (es) 2010-11-08 2013-11-21 Chugai Pharmaceutical Co Ltd Anticuerpo anti-il-6 receptor administrado subcutaneamente.
US20160114048A1 (en) * 2013-05-16 2016-04-28 Universiteit Antwerpen Thermolabile drug release formulation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1055896A (en) * 1963-12-10 1967-01-18 Glaxo Lab Ltd Silica adsorbents in interferon purification and/or concentration
DE2017373A1 (de) * 1969-04-15 1971-04-22 Orsymonde S A , Paris Lyophihsierte Produkte und Ver fahren zu ihrer Herstellung
SE374272B (fi) * 1973-08-31 1975-03-03 D A Safwat
US3932617A (en) * 1974-05-24 1976-01-13 The Upjohn Company Interferon induction
US4357142A (en) * 1980-07-18 1982-11-02 Akzona Incorporated Glass support coated with synthetic polymer for bioprocess
US4363634A (en) * 1980-07-18 1982-12-14 Akzona Incorporated Glass support coated with synthetic polymer for bioprocess
US4414147A (en) * 1981-04-17 1983-11-08 Massachusetts Institute Of Technology Methods of decreasing the hydrophobicity of fibroblast and other interferons
JPS5821691A (ja) * 1981-07-29 1983-02-08 Mochida Pharmaceut Co Ltd α−及びβ−インタ−フェロンの精製方法
JPS5892621A (ja) * 1981-11-28 1983-06-02 Sunstar Inc インタ−フエロンを安定に配合した製剤
EP0082481B2 (en) * 1981-12-23 1990-09-12 Schering Corporation Stabilised alpha-interferon formulations and their preparation
JPS59181224A (ja) * 1983-03-29 1984-10-15 Sumitomo Chem Co Ltd 安定なインタ−フエロン製剤の製法
US4680175A (en) * 1984-02-07 1987-07-14 Interferon Sciences, Inc. Interferon administration vehicles
DE3513288A1 (de) * 1985-04-13 1986-10-23 Dr. Karl Thomae Gmbh, 7950 Biberach Verfahren und vorrichtung zur beaufschlagung von augenstaebchen mit wirkstoffloesungen oder -suspensionen

Also Published As

Publication number Publication date
IL83585A0 (en) 1988-01-31
ZA876166B (en) 1989-05-30
DK434087A (da) 1988-02-22
FI873593A (fi) 1988-02-22
FI89007C (fi) 1993-08-10
NO873513D0 (no) 1987-08-20
NZ221497A (en) 1990-04-26
AU7730787A (en) 1988-02-25
EP0258683A3 (de) 1988-09-07
EP0258683A2 (de) 1988-03-09
DE3628468A1 (de) 1988-03-03
CA1313131C (en) 1993-01-26
KR880002541A (ko) 1988-05-09
PT85561B (pt) 1990-05-31
JPS6351338A (ja) 1988-03-04
NO873513L (no) 1988-02-22
FI89007B (fi) 1993-04-30
PT85561A (de) 1987-09-01
AU590958B2 (en) 1989-11-23
US4824674A (en) 1989-04-25
DK434087D0 (da) 1987-08-20

Similar Documents

Publication Publication Date Title
FI873977A0 (fi) Nya (1h-imidazol-1-ylmetyl) substituerande bensimidazolderivat.
FI872878A (fi) Foerfarande foer framstaellning av nya algininsyraestrar.
FI874287A0 (fi) Nya lymfokinpeptider.
FI873704A0 (fi) Nya ksantinderivat.
FI871406A0 (fi) Foerfarande foer framstaellning av nya aminosyraderivat.
FI875438A (fi) Foerfarande foer framstaellning av nya pyrrolobenzimidazoler.
FI870871A0 (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara peptidderivat.
FI873193A0 (fi) Nya 18-fenylestranderivat.
FI873593A0 (fi) Nya applikationsformer foer -interferon.
FI883257A (fi) Nya peptider.
FI872571A0 (fi) Nya antracykliner.
FI871094A0 (fi) Nya monocykliska estrar.
FI893155A (fi) Nya foereningar.
FI872489A0 (fi) Foerfarande foer framstaellning av nya aralkylimidazolderivat.
FI875766A (fi) Foerfarande foer framstaellning av nya pyrimidinderivat.
FI870626A (fi) Nya polymerbarriaerblandningar.
FI872735A0 (fi) Nya vacciner.
FI872527A0 (fi) Foerfarande foer framstaellning av nya peptider.
FI875130A0 (fi) Nya benzokinoliner.
FI870091A0 (fi) Nya biocider.
FI874885A (fi) Foerfarande foer framstaellning av nya kondenserade cykliska triazolderivat.
FI862751A0 (fi) Nya makromolekyler.
FI884633A0 (fi) Nya malonsyraderivatfoereningar.
FI860837A0 (fi) Nya alfa-aminoalkyl-alfa -alkylfenylacetonitriler.
FI870872A (fi) Nya foereningar.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: DR. KARL THOMAE GESELLSCHAFT MIT